People perceive me as a decisive, goal-oriented, energetic executive and entrepreneur with a record of achievements in starting, building, growing and improving the profitability, performance, and values of companies. I am an effective communicator and people manager with proven leadership talent and build strong teams, motivate and challenge, inspire and empower others to outperform and produce results. By bringing fresh insights to the table, dig into the numbers and devise pragmatic, creative solutions I deliver solutions with a lasting impact. Adapt very easily in any environment and have uncompromising ethics and integrity.
Consultancy, Fast Moving Consumer Goods (FMCG), Gezondheidszorg en welzijnszorg, Handel en retail
Hoogst afgeronde opleidingsniveau
Strategisch, Tactisch, Operationeel
Aantal jaren werkervaring als zelfstandige
Interim Vice President - LEQUEST BV Rotterdam
Professionalized the brand and global strategic relationships of this scale-up in disruptive interactive medical device e-training. Successfully (re-)structured the brand positioning and created strategic partnerships with the leading top 10 medical device leaders (e.g. GE, Philips, Siemens and Merck) resulting in a significantly improved funnel.
Interim C-level - RIVERD BV Rotterdam
Successfully re-structured the commercial and operational departments. Changed strategy from pharma/cosmetics only into the diagnostic oncology healthcare space for an improved brand value and accelerated exit. Adjusted the value proposition, overall quality while lowering production and service cost. Leveraged my leadership talents to re-establish a sustainable balanced work environment. Customers included e.g. J&J, Unilever and P&G.
Commissaris Raad van Bestuur - A-SKIN BV Amsterdam
Requested by investors and founder to join the company to improve the overall ROI. A-SKIN is a skin tissue engineering company founded in 2006 by the VU University Medical Center, departments Dermatology, Oncology and Pathology
Interim Strategic Consultant - INTRASENSE SA (ALINS.PA) – Paris, France
Guided this public French developer of clinical applications software to sustainable profits. Improved strategic partnerships with global leading modality players resulting in improved funnel, increased revenues and margin.
Interim CEO - BIOXYDYN LTD. – MANCHESTER, UK
Bioxydyn Ltd, only company in the world able to commercialize tissue analysis using oxygen as contrast medium for MRI scanners. Successfully changed strategy (focus on Cystic Fibroses vs COPD), introduced the company’s IP to the medical device industry (Siemens & Philips), and accelerated exit for the shareholders.